Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Multicolor monitoring of dysregulated protein kinases in chronic myelogenous leukemia.

Wang Q, Zimmerman EI, Toutchkine A, Martin TD, Graves LM, Lawrence DS.

ACS Chem Biol. 2010 Sep 17;5(9):887-95. doi: 10.1021/cb100099h.

2.

Targeting ABL and SRC kinases in chronic myeloid leukemia: experience with dasatinib.

Quintás-Cardama A, Kantarjian H, Cortes J.

Future Oncol. 2006 Dec;2(6):655-65. Review.

PMID:
17155893
3.

Important therapeutic targets in chronic myelogenous leukemia.

Kantarjian HM, Giles F, Quintás-Cardama A, Cortes J.

Clin Cancer Res. 2007 Feb 15;13(4):1089-97. Review.

4.

Chronic myeloid leukemia and second-generation tyrosine kinase inhibitors: when, how, and which one?

Jabbour E, Kantarjian H, Cortes J.

Semin Hematol. 2010 Oct;47(4):344-53. doi: 10.1053/j.seminhematol.2010.06.002. Review.

PMID:
20875551
5.

New strategies in controlling drug resistance.

Frame D.

J Manag Care Pharm. 2007 Oct;13(8 Suppl A):13-7. Review.

6.

Dual tyrosine kinase inhibitors in chronic myeloid leukemia.

Martinelli G, Soverini S, Rosti G, Baccarani M.

Leukemia. 2005 Nov;19(11):1872-9. Review.

PMID:
16179913
7.

Novel agents in CML therapy: tyrosine kinase inhibitors and beyond.

Melo JV, Chuah C.

Hematology Am Soc Hematol Educ Program. 2008:427-35. doi: 10.1182/asheducation-2008.1.427. Review.

PMID:
19074121
8.

The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib.

Deadman BJ, Hopkin MD, Baxendale IR, Ley SV.

Org Biomol Chem. 2013 Mar 21;11(11):1766-800. doi: 10.1039/c2ob27003j. Epub 2012 Dec 18. Review.

PMID:
23247657
9.

First-line therapy for chronic myeloid leukemia: Past, present, and future.

Pavlovsky C, Kantarjian H, Cortes JE.

Am J Hematol. 2009 May;84(5):287-93. doi: 10.1002/ajh.21380. Review.

10.

Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors.

Ichim CV.

Stem Cells Transl Med. 2014 Apr;3(4):405-15. doi: 10.5966/sctm.2012-0159. Epub 2014 Mar 5. Review.

11.

Kinase packing defects as drug targets.

Crespo A, Fernández A.

Drug Discov Today. 2007 Nov;12(21-22):917-23. Epub 2007 Oct 30. Review. Erratum in: Drug Discov Today. 2014 Apr;19(4):520.

12.

Supplemental Content

Support Center